Syndax Pharmaceuticals (SNDX) EPS (Basic) (2015 - 2026)
Syndax Pharmaceuticals' (SNDX) quarterly EPS (Basic) came in at -$0.48 in Q1 2026, up 51.0% year-on-year from -$0.32 in Q1 2025, and up 28.45% quarter-over-quarter from -$0.67 in Q4 2025.
Syndax Pharmaceuticals (SNDX) EPS (Basic) (2015 - 2026) Analysis & Trends
Syndax Pharmaceuticals' EPS (Basic) history runs 12 years deep, the most recent figure standing at -$0.48 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 51.0% year-over-year to -$0.48 in Q1 2026; TTM through Mar 2026 was -$2.68, a 31.57% increase from a year earlier, with the FY2025 full-year figure at -$3.55, up 46.93% from the prior year.
- EPS (Basic) rose to -$0.48 in Q1 2026 per SNDX's latest filing, from -$0.67 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.48 in Q1 2026 and bottomed at -$1.1 in Q4 2024.
- The 5-year median for EPS (Basic) is -$0.73 (2023), against an average of -$0.77.
- Across the five-year window, EPS (Basic) plunged 131.05% in 2022 and soared 51.0% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at -$0.57 in 2022, then sank by 42.83% to -$0.81 in 2023, then sank by 35.36% to -$1.1 in 2024, then soared by 38.87% to -$0.67 in 2025, then rose by 28.45% to -$0.48 in 2026.
- Per Business Quant, the three latest SNDX EPS (Basic) figures stand at -$0.48 (Q1 2026), -$0.67 (Q4 2025), and -$0.7 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn | -0.48 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.48 |
| Dec 31, 2025 | -0.67 |
| Sep 30, 2025 | -0.70 |
| Jun 30, 2025 | -0.88 |
| Mar 31, 2025 | -0.98 |
| Dec 31, 2024 | -1.10 |
| Sep 30, 2024 | -0.99 |
| Jun 30, 2024 | -0.88 |
| Mar 31, 2024 | -0.95 |
| Dec 31, 2023 | -0.81 |
| Sep 30, 2023 | -0.74 |
| Jun 30, 2023 | -0.73 |
| Mar 31, 2023 | -0.66 |
| Dec 31, 2022 | -0.57 |
| Sep 30, 2022 | -0.58 |
| Jun 30, 2022 | -0.66 |
| Mar 31, 2022 | -0.65 |
| Dec 31, 2021 | 1.83 |
| Sep 30, 2021 | -0.40 |
| Jun 30, 2021 | -0.44 |